NBT Bank N A NY reduced its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 4.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 43,935 shares of the conglomerate's stock after selling 1,841 shares during the period. NBT Bank N A NY's holdings in Danaher were worth $9,007,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter valued at about $27,000. Hurley Capital LLC purchased a new stake in Danaher in the fourth quarter worth approximately $34,000. Rialto Wealth Management LLC bought a new position in Danaher during the fourth quarter valued at approximately $34,000. Rakuten Securities Inc. raised its stake in shares of Danaher by 380.0% during the fourth quarter. Rakuten Securities Inc. now owns 168 shares of the conglomerate's stock worth $39,000 after acquiring an additional 133 shares in the last quarter. Finally, Ameriflex Group Inc. purchased a new position in shares of Danaher during the fourth quarter worth approximately $38,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently commented on DHR. Wall Street Zen lowered shares of Danaher from a "buy" rating to a "hold" rating in a report on Monday, June 9th. Deutsche Bank Aktiengesellschaft reduced their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Argus lowered their target price on Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Guggenheim restated a "buy" rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Finally, Wells Fargo & Company decreased their price target on Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $248.17.
Check Out Our Latest Research Report on DHR
Insider Activity
In other news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. The trade was a 51.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.
Danaher Price Performance
Shares of NYSE DHR opened at $201.14 on Tuesday. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The stock has a market capitalization of $143.95 billion, a P/E ratio of 38.09, a P/E/G ratio of 2.66 and a beta of 0.77. The company's 50-day moving average is $193.35 and its 200 day moving average is $210.53. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, sell-side analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.64%. Danaher's dividend payout ratio (DPR) is presently 24.85%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.